Meeting
2014 ASCO Annual Meeting
The role of pazopanib in various histologic subtypes of metastatic soft tissue sarcomas.
Authors
Kwai Han Yoo
Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Kwai Han Yoo , Seung Tae Kim , Jeeyun Lee , Se Hoon Park , Sung Joo Kim , Hyo Song Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 10586)
DOI
10.1200/jco.2014.32.15_suppl.10586
Abstract #
10586
Poster Bd #
293
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Pazopanib for soft tissue sarcoma (STS) in the first- line setting with denosumab.
First Author: Hiroyuki Narahara
Poster
2020 Genitourinary Cancers Symposium
Outcomes of adult urogenital sarcomas: Analysis of surveillance, epidemiology, and end results (SEER) database 2004 to 2015.
First Author: Snigdha Nutalapati
Poster
2018 ASCO Annual Meeting
Treatment of angiosarcoma with pazopanib and paclitaxel: Results of the phase II trial of the German Interdisciplinary Sarcoma Group (GISG-06 EVA) study.
First Author: Daniel Pink
Poster
2017 ASCO Annual Meeting
Rates of survival throughout the years in soft tissue sarcoma with synchronous metastases: Results of a population-based study.
First Author: Melissa Vos